Avid Bioservices, Inc.

CDMO · NASDAQ
Analyze with AI
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Operating Activities
Net Income-$140,753$560$127,672$11,212
Dep. & Amort.$11,109$7,210$4,480$3,453
Deferred Tax$113,823$1,443-$115,082$0
Stock-Based Comp.$9,731$10,978$7,380$3,854
Change in WC$13,447-$34,263-$16,396$11,747
Other Non-Cash$3,595$1,185$1,411$916
Operating Cash Flow$10,952-$12,887$9,465$31,182
Investing Activities
PP&E Inv.-$31,805-$77,638-$56,411-$9,864
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$77,638-$56,411-$9,864
Investing Cash Flow-$31,805-$77,638-$56,411-$9,864
Financing Activities
Debt Repay.$17,325-$505-$162$133,992
Stock Issued$1,396$3,406$3,359$36,125
Stock Repurch.$0$0$0-$40,490
Dividends Paid$0$0$0-$4,455
Other Fin. Act.$2,742$3,406$3,359-$57,692
Financing Cash Flow$20,067$2,901$3,197$112,335
Forex Effect$0$90,821$0$0
Net Chg. in Cash-$786-$87,624-$43,749$133,653
Supplemental Information
Beg. Cash$38,892$126,516$170,265$36,612
End Cash$38,106$38,892$126,516$170,265
Free Cash Flow-$20,853-$90,525-$46,946$21,318